Literature DB >> 27644094

Intranasal oxytocin administration improves depression-like behaviors in adult rats that experienced neonatal maternal deprivation.

Haoyi Ji1, Wenlong Su, Ruchen Zhou, Jing Feng, Yue Lin, Yumin Zhang, Xinmei Wang, Xiaoyang Chen, Jing Li.   

Abstract

Oxytocin (OT), a hypothalamic neuropeptide, has been implicated in the regulation of social behaviors in rodents and humans. This study assessed the effects of intranasal administration of OT on depressive-like behaviors and hippocampal neurogenesis in adult rats following neonatal maternal deprivation (NMD). Here, we show that NMD resulted in significant depression-like behaviors, as indicated by decreases in physical activity and emotional reactivity in a novel environment, in 2-month-old animals. Notably, the OT levels in the plasma, hypothalamus, and hippocampus were decreased in these animals. Intranasal administration of OT reduced the depressive-like behaviors in NMD rats and rescued hippocampal long-term plasticity impaired by NMD stress in rats by promoting hippocampal neurogenesis. These results indicate that OT alleviates the depressive-like behaviors in NMD adult rats, probably mediated by improving adult hippocampal neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27644094     DOI: 10.1097/FBP.0000000000000248

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  7 in total

Review 1.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

2.  Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats.

Authors:  Jennifer L Cornish; Nicholas A Everett; Sarah J Baracz; Katherine J Robinson; Amanda L Wright; Anita J Turner; Iain S McGregor
Journal:  Neuropsychopharmacology       Date:  2022-05-17       Impact factor: 8.294

Review 3.  Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.

Authors:  Michael T Bardo; Lindsey R Hammerslag; Samantha G Malone
Journal:  Neuropharmacology       Date:  2021-04-13       Impact factor: 5.273

4.  Depression from the perspective of modern and Persian medicine.

Authors:  Majid Anushiravani; Ali Akhondpour Manteghi; Ali Taghipur; Mahdi Eslami
Journal:  Electron Physician       Date:  2018-02-25

Review 5.  Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin.

Authors:  Maria Antonietta Panaro; Tarek Benameur; Chiara Porro
Journal:  J Clin Med       Date:  2020-05-19       Impact factor: 4.241

6.  Comparison of the pharmacologic profiles of arginine vasopressin and oxytocin analogs at marmoset, titi monkey, macaque, and human oxytocin receptors.

Authors:  Marsha L Pierce; Jeffrey A French; Thomas F Murray
Journal:  Biomed Pharmacother       Date:  2020-02-01       Impact factor: 6.529

Review 7.  Roles of Oxytocin in Stress Responses, Allostasis and Resilience.

Authors:  Yuki Takayanagi; Tatsushi Onaka
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.